Research programme cancer therapeutics - Halda Therapeutics
Latest Information Update: 31 Mar 2023
At a glance
- Originator Halda Therapeutics
- Class Antineoplastics; Proteins; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer